Arovella Therapeutics Limited

Arovella Therapeutics Limitedverified

ALA.AX

Price:

$0.078

Market Cap:

$93.66M

Arovella Therapeutics Limited, a biotechnology company, focuses on the development of therapies for the treatment of cancer and conditions that affect the central nervous system in Australia and internationally. Its product pipeline includes ZolpiMist, an oral spray of zolpidem tartrate to treat short-term insomnia, which is marketed under the brand name of Ambien or Stilnox; invariant natural killer T (iNKT), a cell therapy platform to treat blood cancer; OroMist, an oro-mucosal technology that delivers a range of drug classes through the cheeks, gums, tongue, or floor of the mouth; and Anagrelide to treat cancer. The company also develops oral sprays to treat migraine headaches, motion sic...[Read more]

Industry

Biotechnology

IPO Date

2002-01-22

Stock Exchange

ASX

Ticker

ALA.AX

The PE Ratio as of December 2025 (TTM) for Arovella Therapeutics Limited (ALA.AX) is -7.80

According to Arovella Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -7.80. This represents a change of -36.55% compared to the average of -12.29 of the last 4 quarters.

Arovella Therapeutics Limited (ALA.AX) Historical PE Ratio (quarterly & annually)

How has ALA.AX PE Ratio performed in the past?

The mean historical PE Ratio of Arovella Therapeutics Limited over the last ten years is -6.78. The current -7.80 PE Ratio has changed 11.41% with respect to the historical average. Over the past ten years (40 quarters), ALA.AX's PE Ratio was at its highest in in the June 2003 quarter at 0. The PE Ratio was at its lowest in in the December 2013 quarter at -35.00.

Quarterly (TTM)
Annual

Average

-6.78

Median

-3.62

Minimum

-17.74

Maximum

-0.53

Arovella Therapeutics Limited (ALA.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Arovella Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 605.96%

Maximum Annual PE Ratio = -0.53

Minimum Annual Increase = -89.91%

Minimum Annual PE Ratio = -17.74

Quarterly (TTM)
Annual
YearPE RatioChange
2025-14.61-6.37%
2024-15.61346.70%
2023-3.49138.27%
2022-1.47-60.76%
2021-3.74605.96%
2020-0.53-58.15%
2019-1.26-29.36%
2018-1.79-89.91%
2017-17.74135.50%
2016-7.53-10.84%

Arovella Therapeutics Limited (ALA.AX) Average PE Ratio

How has ALA.AX PE Ratio performed in the past?

The current PE Ratio of Arovella Therapeutics Limited (ALA.AX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-11.24

5-year avg

-7.78

10-year avg

-6.78

Arovella Therapeutics Limited (ALA.AX) PE Ratio vs. Peers

How is ALA.AX’s PE Ratio compared to its peers?

Arovella Therapeutics Limited’s PE Ratio is greater than Island Pharmaceuticals Limited (-25.68), less than Alterity Therapeutics Limited (-5.54), less than Imugene Limited (-1.11), greater than Actinogen Medical Limited (-10.95), less than Recce Pharmaceuticals Ltd (-6.80), less than EZZ Life Science Holdings Limited (10.94), less than Biome Australia Limited (403.72), less than Amplia Therapeutics Limited (-6.70), less than Alcidion Group Limited (86.75), greater than PainChek Limited (-12.48),

Build a custom stock screener for Arovella Therapeutics Limited (ALA.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arovella Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arovella Therapeutics Limited (ALA.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arovella Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Arovella Therapeutics Limited's PE Ratio?

How is the PE Ratio calculated for Arovella Therapeutics Limited (ALA.AX)?

What is the highest PE Ratio for Arovella Therapeutics Limited (ALA.AX)?

What is the 3-year average PE Ratio for Arovella Therapeutics Limited (ALA.AX)?

What is the 5-year average PE Ratio for Arovella Therapeutics Limited (ALA.AX)?

How does the current PE Ratio for Arovella Therapeutics Limited (ALA.AX) compare to its historical average?